rasagiline has been researched along with Adverse Drug Event in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Bergmans, B; Bourgeois, P; Cras, P; De Klippel, N; Dethy, S; Franco, G; Garraux, G; Geens, K; Jacquerye, P; Jeanjean, A; Krygier, C; Supiot, F; Van der Linden, C | 1 |
Cao, S; Chen, H; Hu, X; Liang, Z; Liu, Z; Mao, W; Shao, M; Song, Z; Su, W; Tang, B; Wei, W; Wu, Y; Zhang, K | 1 |
Hattori, N; Kitagawa, T; Mochizuki, H; Nagai, M; Nishimura, A; Takahashi, R; Takeda, A; Takeda, S | 1 |
Chen, JJ; Conner, J; Mathena, J; Panisset, M; Rhyee, SH | 1 |
Perez-Lloret, S; Rascol, O | 1 |
1 review(s) available for rasagiline and Adverse Drug Event
Article | Year |
---|---|
Safety of rasagiline for the treatment of Parkinson's disease.
Topics: Animals; Clinical Trials as Topic; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Food-Drug Interactions; Humans; Indans; Parkinson Disease; Serotonin Agents; Treatment Outcome | 2011 |
1 trial(s) available for rasagiline and Adverse Drug Event
Article | Year |
---|---|
Rasagiline monotherapy in early Parkinson's disease: A phase 3, randomized study in Japan.
Topics: Adult; Aged; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Indans; Japan; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nasopharyngitis; Outcome Assessment, Health Care; Parkinson Disease; Severity of Illness Index | 2019 |
4 other study(ies) available for rasagiline and Adverse Drug Event
Article | Year |
---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study.
Topics: Aged; Antiparkinson Agents; Belgium; Drug-Related Side Effects and Adverse Reactions; Humans; Levodopa; Parkinson Disease; Prospective Studies; Retrospective Studies | 2023 |
Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson's Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study.
Topics: Cohort Studies; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; East Asian People; Humans; Levodopa; Parkinson Disease; Prospective Studies; Treatment Outcome | 2023 |
Serotonin toxicity association with concomitant antidepressants and rasagiline treatment: retrospective study (STACCATO).
Topics: Aged; Antidepressive Agents, Second-Generation; Cohort Studies; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Indans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; United States | 2014 |